top of page
.png){kind=logo}
NEWS & BLOGS
Blog: Blog2
![[FDA Regulation] Get Ready for the New FDA Medical Device CGMP Rule: A Glimpse of Final Rule](https://static.wixstatic.com/media/7ffba2_0905ef2660dd4360800a728828ee5de6~mv2.jpg/v1/fill/w_1663,h_1000,fp_0.50_0.50,q_30,blur_30,enc_avif,quality_auto/7ffba2_0905ef2660dd4360800a728828ee5de6~mv2.jpg)
![[FDA Regulation] Get Ready for the New FDA Medical Device CGMP Rule: A Glimpse of Final Rule](https://static.wixstatic.com/media/7ffba2_0905ef2660dd4360800a728828ee5de6~mv2.jpg/v1/fill/w_1816,h_1092,fp_0.50_0.50,q_90,enc_avif,quality_auto/7ffba2_0905ef2660dd4360800a728828ee5de6~mv2.jpg)
[FDA Regulation] Get Ready for the New FDA Medical Device CGMP Rule: A Glimpse of Final Rule
Date: 1/31/2024 The Food and Drug Administration (FDA) has announced the issuance of a device final rule aimed at amending the current...
Provision Consulting Group
Jan 31, 20242 min read
FDA’s MoCRA Cosmetics Portal is Open: A Game-Changer for Industry Compliance
Date: 12/19/2023 FDA’s MoCRA Cosmetics Portal is Open! Cosmetics Constituent Update: December 18, 2023 In a significant move, the U.S....
Provision Consulting Group
Dec 19, 20232 min read
Acquisition of 510(k) Certification: Ensuring Optimal Efficiency - Dental Implant Excellence
Date: 11/17/2023 Supported by the expertise of Provision Consulting Group, a leading global dental implant enterprise swiftly secured...
Provision Consulting Group
Nov 17, 20231 min read
K-Beauty Expo Keynote: FDA Cosmetic Law MoCRA Compliance Insights from PCG Expertise
Date: 11/17/2023 At the K Beauty Expo hosted by KINTEX on October 13th, Provision Consulting Group's co-CEO, Sung Kwon, served as a...
Provision Consulting Group
Nov 17, 20232 min read
FDA Postpones Cosmetic Facility Registration Enforcement: Navigating MoCRA Compliance Landscape
Date: 11/10/2023 In a recent announcement on November 8, 2023, the FDA communicated a deferment in the enforcement date for cosmetic...
Provision Consulting Group
Nov 10, 20233 min read
![[FDA News] October 12th Webinar_Use of ISO 10993-1 (Biocompatibility) Final Guidance](https://static.wixstatic.com/media/22ea40_35fa4598ad6a47779363956b8e23a647~mv2.jpg/v1/fill/w_999,h_667,fp_0.50_0.50,q_30,blur_30,enc_avif,quality_auto/22ea40_35fa4598ad6a47779363956b8e23a647~mv2.jpg)
![[FDA News] October 12th Webinar_Use of ISO 10993-1 (Biocompatibility) Final Guidance](https://static.wixstatic.com/media/22ea40_35fa4598ad6a47779363956b8e23a647~mv2.jpg/v1/fill/w_999,h_667,fp_0.50_0.50,q_90,enc_avif,quality_auto/22ea40_35fa4598ad6a47779363956b8e23a647~mv2.jpg)
[FDA News] October 12th Webinar_Use of ISO 10993-1 (Biocompatibility) Final Guidance
The U.S. Food and Drug Administration (FDA) will host a webinar to share information and answer questions about the final guidance Use of...
Provision Consulting Group
Oct 6, 20231 min read
FDA Approves First Extended-Release, Injectable Drug Regimen for Adults Living with HIV
On January 21, The U.S. Food and Drug Administration approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a...
Provision Consulting Group
Jan 29, 20212 min read
bottom of page